$AMBQ

Ambiq Micro CFO Winzeler sells $379,644 in stock

Ambiq Micro's CFO, Jeffrey Winzeler, sold 5,455 shares for $379,644 in three transactions, citing tax obligations. He now owns 100,844 shares. AMBQ stock fell 14% to $58.56. The company reported 89.7% revenue growth to $33.9M in Q2, narrowing losses to $1.8M. Analysts have mixed views, with price targets ranging from $73 to $85, except BofA's $75 underperform rating.

Original reporting
Published Oct 11, 2026, 7:46 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 11, 2026, 11:05 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$AMBQ
Bearish
medium confidence
Mentioned
$AMBQ
Relevance
4/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$AMBQBearishLow
01

Why it matters

The insider sale adds a short‑term bearish catalyst despite positive earnings momentum.

02

Market read

The article combines a fresh insider sale with strong earnings data, offering mixed signals for traders.

03

What to watch

Strong Q2 revenue growth and raised guidance may offset the negative signal from the insider sale.

Relevance 4/10Novelty 5/10Timing: recently reported

Background

Ambiq Micro reported an 89.7% YoY revenue increase and raised its full‑year outlook, while analysts upgraded price targets.

Company-level read

Ticker impact

$AMBQBearishMedium confidence
Context

CFO Jeffrey Winzeler sold 5,455 shares for $379,644, a Form 4 insider sale disclosed in the article.

Expected impact

likely downward pressure as the market prices in the insider sell

Evidence & confidence

Insider sales, especially by a CFO, often lead to short-term sell‑offs, and the stock has already fallen 14% this week.

Market effects

Minimal impact on the broader semiconductor sector; the sale is company‑specific.

No significant regional effect; Ambiq Micro trades primarily on US exchanges.

Limited global relevance beyond investors tracking micro‑cap AI chip makers.

Counterpoint

The sale could be routine tax‑related liquidity need, not a lack of confidence.

Key entities

  • Jeffrey Winzeler

    Chief Financial Officer of Ambiq Micro

  • Ambiq Micro Inc.

    Developer of low‑power edge AI chips

Related articles

$AMBQMed

Jefferies initiates Ambiq Micro stock with buy rating on AI edge computing potential

Jefferies initiated coverage on Ambiq Micro (NYSE: AMBQ) with a buy rating and $90 price target, citing its AI edge computing potential. The company's SPOT architecture offers power advantages for edge devices. Ambiq Micro reported 89.7% revenue growth in Q2, with full-year sales outlook raised to $135 million. Several analysts revised earnings upwards, and multiple firms increased price targets.

Med

Ambiq Micro, Inc. Q2 2026 Earnings Call Summary

Ambiq Micro reported Q2 2026 results and said revenue rose 90% year over year, driven by stronger Edge AI demand and growth across Apollo II and Apollo IV, with Apollo V more than doubling on a new large customer ramp. Management projected Q3 net sales up ~100% YoY and 2026 revenue about $135M, despite supply constraints limiting shipments. Gross margin expected to improve modestly in 2026.

Med

Ambiq Micro Q2 net loss narrows to US$7.1 million as edge AI sales surge

Ambiq Micro reported Q2 net loss of $7.1 million, or $0.32 per share, narrowing from $8.5 million a year earlier, as revenue rose 89.7% on stronger demand for ultra-low power edge AI chips. Q2 gross profit more than doubled to $15.3 million and gross margin rose to 45%. H1 net loss was $17.3 million. Cash was $366.8 million after a June follow-on raising $167.9 million net proceeds.

$AMBQHighAI 9/10

Ambiq (AMBQ) Q2 2026 Earnings Call Transcript

Ambiq Micro (AMBQ) reported Q2 2026 net sales of $33.9 million, up 89.7% year over year, citing accelerating edge AI demand. Non-GAAP gross margin was 47.2%. Full-year net sales guidance is about $135 million, with Q3 revenue outlook of $36 million to $37 million. Management cited supply constraints limiting order fulfillment and said cash was $366.8 million as of June 30, 2026.

$AMBQHigh

Ambiq Reports Second Quarter 2026 Financial Results

Ambiq Micro, Inc. (AMBQ) filed an SEC Form 8-K — Results of Operations and Financial Condition. Ambiq Reports Second Quarter 2026 Financial Results Delivered record quarterly net sales, increasing approximately 90% year-over-year, driven by strong demand for edge AI solutions Gross profit more than doubled year-over-year on higher net sales and margin expansion Expect third

$SYKMed

Stryker Names Spencer Stiles CEO as CMR Surgical Investment Advances

Stryker Corporation has appointed Spencer Stiles as its next CEO, effective January 1, 2027. Current CEO Kevin Lobo will become executive chair. The company also announced a $400 million investment in CMR Surgical to support its Versius surgical robotics portfolio. Stryker reported Q2 2026 revenue of $6.59 billion, a 9.40% increase year-over-year, with adjusted earnings per share of $3.69, exceeding estimates.